KAN Consulting Founded in 2010 by Kamila A. Novak, MSc, KAN Consulting collaborates with and provides expert solutions to biotechnology and pharmaceutical companies as well as start-ups and spin-offs to facilitate their medicinal product development, manage research projects, identify and manage risks, thus, meeting their targets on time with the desired quality and within budget. Apart from biotech and pharma, our client portfolio includes other key players in the R&D field, namely, institutions, individual researchers – investigators, and CROs. Our goal is to optimise drug development cost and time from discovery through Proof of Concept to the market, while maintaining the regulatory-required participants’ safety, data quality and integrity, so that patients may benefit from new therapies as soon as possible.